Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Aidapak Services is recalling Warfarin Sodium 0.5 mg tablets because they may be mislabeled as Sodium Chloride 1 mg tablets.
Aidapak Services, LLC is recalling Cholecalciferol/Calcium/Phosphorus tablets because they may be mislabeled as Promethazine HCl or Valsartan.
Specialty Medicine Compounding Pharmacy is recalling Glycerin-Chromated 72% Injectable because sterility cannot be assured after a related product was found non-sterile.
Aidapak Services is recalling Rivaroxaban 20 mg tablets that may be mislabeled as Venlafaxine HCL 100 mg due to a label mixup.
Aidapak Services is recalling 400 mg ibuprofen tablets that may be mislabeled as 325 mg aspirin. The repacked drugs were distributed in four western states.
Specialty Medicine Compounding Pharmacy is recalling all unexpired sterile compounded human and veterinary products because sterility cannot be assured due to shared compounding practices with a non-sterile product.
Specialty Medicine Compounding Pharmacy is recalling 0.9% Sodium Chloride injectable and topical products because sterility cannot be assured after a related product was found non-sterile.
Aidapak Services, LLC is recalling Docusate Sodium capsules because they may be mislabeled as other medications. The affected products were distributed in four western states.
Aidapak Services, LLC is recalling TACROLIMUS Capsules, 1 mg, because they may be mislabeled as LEVOTHYROXINE SODIUM Tablets, 125 mcg.
Specialty Medicine Compounding Pharmacy is recalling Proparacaine HCl ophthalmic solution because sterility cannot be assured due to shared compounding practices with a non-sterile product.
Specialty Medicine Compounding Pharmacy is recalling Tropicamide 1% Ophthalmic Solution because sterility cannot be assured after a related product was found non-sterile.
Specialty Medicine Compounding Pharmacy is recalling fluconazole and gentamicin solution because sterility cannot be assured after a related product was found non-sterile.
Aidapak Services is recalling Losartan Potassium tablets that may be mislabeled as Disopyramide Phosphate. The error involves a label mixup on repacked drugs.
Aidapak Services, LLC is recalling Selegiline HCL 5 mg capsules because they may be mislabeled as Itraconazole 100 mg. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling GuaiFENesin ER 600 mg tablets because they may be mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Propranolol HCL 10 mg tablets that may be mislabeled as Pioglitazone HCL 15 mg. The repacked drugs were distributed in four western states.
Specialty Medicine Compounding Pharmacy is recalling Vancomycin HCL 10 mg/mL Ophthalmic Solution because sterility cannot be assured. The product was distributed to healthcare providers and patients in Michigan.
Specialty Medicine Compounding Pharmacy is recalling Triple Mix injectable products because sterility cannot be assured after a related product was found non-sterile.
Aidapak Services is recalling Pimozide 1 mg tablets that may be mislabeled as Metoprolol Tartrate 12.5 mg. The error poses a risk of incorrect medication administration.
Aidapak Services, LLC is recalling Olanzapine 7.5 mg tablets because they may be mislabeled as Levothyroxine or Mirtazapine. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling 10 mg Citalopram tablets because they may be mislabeled as Oxybutynin Chloride or Coenzyme Q-10.
Specialty Medicine Compounding Pharmacy is recalling Papav/Phentol/PG E1 injectable products because sterility cannot be assured after a related product was found non-sterile.
Aidapak Services, LLC is recalling prenatal multivitamin tablets that may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Specialty Medicine Compounding Pharmacy is recalling Hydroxocobalamin/Thiamine Injectable due to lack of assurance of sterility. The product was distributed to healthcare providers in Michigan.
Specialty Medicine Compounding Pharmacy is recalling Potassium Phosphate injectable products because sterility cannot be assured after a related product was found non-sterile.